Dos Santos F, Brin M, Tanner M, Galindo C, Schnall R
JMIR Hum Factors. 2025; 12:e59780.
PMID: 40019786
PMC: 11887583.
DOI: 10.2196/59780.
Carneiro P, Radix A, Golub S, Grosskopf N, Grov C
J Acquir Immune Defic Syndr. 2025; 97(4):357-363.
PMID: 39808073
PMC: 11733312.
DOI: 10.1097/QAI.0000000000003492.
Traeger M, Leyden W, Volk J, Silverberg M, Horberg M, Davis T
JAMA Intern Med. 2025; 185(3):273-281.
PMID: 39761062
PMC: 11877173.
DOI: 10.1001/jamainternmed.2024.7186.
Shuper P, Joharchi N, Varatharajan T, Bogoch I, Loutfy M, El-Helou P
BMC Public Health. 2024; 24(1):3487.
PMID: 39696067
PMC: 11658148.
DOI: 10.1186/s12889-024-20934-7.
Horton H, Marshall S, Gu M, Tody B, Jackson T, Zaller N
PLoS One. 2024; 19(12):e0312667.
PMID: 39621654
PMC: 11611198.
DOI: 10.1371/journal.pone.0312667.
A snapshot of the presence of HIV-related features in MSM social media dating apps in New Zealand.
Li W, Wu D, Xing Z, Chen Z
Sci Rep. 2024; 14(1):22690.
PMID: 39349684
PMC: 11443115.
DOI: 10.1038/s41598-024-74067-3.
Routine Testing for Chlamydia and Gonorrhea in an HIV Pre-Exposure Prophylaxis Program in Hanoi, Vietnam: Implications for Low- and Middle-Income Countries.
Adamson P, Bui H, Pham L, Truong P, Giang L, LE N
medRxiv. 2024; .
PMID: 39252902
PMC: 11383485.
DOI: 10.1101/2024.08.30.24312811.
Acceptability of an automated directly observed therapy (DOT) application for PrEP adherence support among young men who have sex with men: a qualitative exploration.
Velloza J, Liu A, Katz A, van der Straten A, Siegler A, Scott H
AIDS Care. 2024; 36(11):1704-1718.
PMID: 39222964
PMC: 11511627.
DOI: 10.1080/09540121.2024.2397133.
Pharmacologic Drug Detection and Self-Reported Adherence in the HPTN069/ACTG5305 Phase II PrEP Trial.
Cooper S, Zhang S, Haines D, Mayer K, Amico K, Landovitz R
AIDS Behav. 2024; 28(11):3710-3718.
PMID: 39083151
PMC: 11471692.
DOI: 10.1007/s10461-024-04451-7.
The Association between Social Support and Pre-Exposure Prophylaxis use among Sexual Minority Men in the United States: A Scoping Literature Review.
Nacht C, Reynolds H, Jessup O, Amato M, Storholm E
AIDS Behav. 2024; 28(11):3559-3573.
PMID: 39039399
PMC: 11471694.
DOI: 10.1007/s10461-024-04446-4.
Low Self-Perceived Need for PrEP and Behavioral Indications of MSM Who Recently Refused Daily PrEP: A Mixed Methods Study in Three U.S. Cities.
Kota K, Gelaude D, Carnes N, Schoua-Glusberg A, Frew P, Randall L
AIDS Behav. 2024; 28(6):1845-1857.
PMID: 38457051
PMC: 11216258.
DOI: 10.1007/s10461-024-04276-4.
Perspectives on unhealthy alcohol use among men who have sex with men prescribed HIV pre-exposure prophylaxis: A qualitative study.
Strong S, Oldfield B, Berg J, Cole C, Biegacki E, Ogbuagu O
Prev Med Rep. 2024; 37:102553.
PMID: 38282665
PMC: 10810836.
DOI: 10.1016/j.pmedr.2023.102553.
Demographics, Trends, and Clinical Characteristics of HIV Pre-Exposure Prophylaxis Recipients and People Newly Diagnosed with HIV from Large Electronic Health Records in Florida.
Liu Y, Siddiqi K, Cho H, Park H, Prosperi M, Cook R
AIDS Patient Care STDS. 2024; 38(1):14-22.
PMID: 38227279
PMC: 10794838.
DOI: 10.1089/apc.2023.0220.
Sexually Transmitted Infection Prevention Perspectives in Black Men Who Have Sex With Men Taking Preexposure Prophylaxis in New Orleans.
Clement M, Beckford J, Lovett A, Siren J, Adorno M, LeGrand S
Sex Transm Dis. 2023; 51(2):90-95.
PMID: 38100815
PMC: 10872490.
DOI: 10.1097/OLQ.0000000000001908.
A Decade of HIV Preexposure Prophylaxis (PrEP): Overcoming Access Barriers in the United States Through Expanded Delivery.
Jackson K, McCoy S, White D
Public Health Rep. 2023; 139(4):405-411.
PMID: 38032345
PMC: 11284973.
DOI: 10.1177/00333549231208487.
State same-sex marriage policies and pre-exposure prophylaxis implementation among men who have sex with men in the United States.
Raifman J, Cheng D, Skinner A, Hatzenbuehler M, Mayer K, Stein M
J Int AIDS Soc. 2023; 26(11):e26180.
PMID: 37997001
PMC: 10667585.
DOI: 10.1002/jia2.26180.
Factors Associated with Planned Future Use of PrEP in the Next 3 Months and Likelihood to Use PrEP Among Black Cisgender HIV-negative Women in Texas.
Sophus A, Mitchell J, Barroso J, Sales J
AIDS Behav. 2023; 28(1):72-92.
PMID: 37768428
DOI: 10.1007/s10461-023-04188-9.
HIV pre-exposure prophylaxis: It is time to consider harm reduction care for adolescents in Canada.
Leonard S, Sotindjo T, Brophy J, Tan D, Nashid N
Paediatr Child Health. 2023; 28(6):338-343.
PMID: 37744752
PMC: 10517249.
DOI: 10.1093/pch/pxac115.
Sociodemographic and Behavioral Risk Correlates of PrEP Interest and Use Among Young Adults Experiencing Homelessness in Los Angeles.
Storholm E, Klein D, Pedersen E, DAmico E, Rodriguez A, Garvey R
AIDS Behav. 2023; 28(4):1216-1226.
PMID: 37698638
PMC: 10927607.
DOI: 10.1007/s10461-023-04144-7.
HIV pre-exposure prophylaxis and incidence of sexually transmitted infections in Brazil, 2018 to 2022: An ecological study of PrEP administration, syphilis, and socioeconomic indicators.
Gil P, Conrado D, Nascimento A, Azevedo M, Pereira da Cunha J, Serrano Ramires Koch G
PLoS Negl Trop Dis. 2023; 17(8):e0011548.
PMID: 37566639
PMC: 10446216.
DOI: 10.1371/journal.pntd.0011548.